Overview

An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG).
Phase:
Phase 3
Details
Lead Sponsor:
XOMA (US) LLC